Sold Out
Book Categories |
1 | Epidemiology of primary biliary cirrhosis | 3 |
2 | Genetic components of primary biliary cirrhosis | 13 |
3 | Infectious aetiology of primary biliary cirrhosis | 27 |
4 | Gender and primary biliary cirrhosis : is microchimerism an aetiological factor? | 37 |
5 | Histology of autoimmune cholestatic liver diseases | 47 |
6 | Mechanisms of biliary epithelial cell apoptosis in primary biliary cirrhosis | 56 |
7 | Role of autoantibodies and autoantigens in primary biliary cirrhosis | 69 |
8 | Clinical aspects and prognosis of primary biliary cirrhosis | 79 |
9 | Pathogenesis of pruritus and fatigue in cholestatic liver disease | 94 |
10 | Is osteoporosis a specific complication of primary biliary cirrhosis? | 110 |
11 | Diseases associated with primary biliary cirrhosis | |
12 | Overlap syndromes, outlier syndromes and changing diagnoses | 125 |
13 | The autoimmune hepatitis/hepatitis C overlap syndrome : does it exist? | 132 |
14 | Histopathology of overlap syndromes in the liver | 147 |
15 | Mechanisms of action of ursodeoxycholic acid in cholestasis | 161 |
16 | Primary biliary cirrhosis : long-term therapy with ursodeoxycholic acid | 171 |
17 | Combination therapy of primary biliary cirrhosis and overlap syndromes | 179 |
18 | Management of pruritus, fatigue and bone disease in patients with primary biliary cirrhosis | 188 |
19 | Liver transplantation, rejection and disease recurrence | 197 |
20 | Primary sclerosing cholangitis : diagnosis and differential diagnosis | 203 |
21 | Incidence and prevalence of primary sclerosing cholangitis around the world | 218 |
22 | Small duct primary sclerosing cholangitis : a separate disease? | 225 |
23 | Prognosis of untreated primary sclerosing cholangitis | 231 |
24 | Is primary sclerosing cholangitis an autoimmune disease? | 243 |
25 | Autoimmune markers and their role in the pathogenesis of primary sclerosing cholangitis | 247 |
26 | The HLA system and other genetic markers in primary sclerosing cholangitis | 257 |
27 | Viruses, protozoans, bacteria and drugs as aetiological factors in primary sclerosing cholangitis | 273 |
28 | Primary sclerosing cholangitis and inflammatory bowell disease : when and how to they relate to each other? | 283 |
29 | Extrahepatic and extraintestinal manifestations of primary sclerosing cholangitis | 289 |
30 | Primary sclerosing cholangitis in paediatrics : what is different? | 293 |
31 | Ursodeoxycholic acid : high-dose, monotherapy or combination therapy? | 301 |
32 | Endoscopic treatment of dominant stenoses in patients with primary sclerosing cholangitis | 309 |
33 | How should and how does antifibrotic therapy act in biliary fibrosis? | 314 |
34 | Ursodeoxycholic acid to prevent colon cancer in primary sclerosing cholangitis | 323 |
35 | Hepatocellular carcinoma, cholangiocarcinoma, colon and pancreatic carcinoma in patients with primary sclerosing cholangitis : epidemiology and risk factors | 335 |
36 | Tumour markers and genetic markers in the diagnosis of bile duct carcinoma | 345 |
37 | Histology and brush cytology for diagnosis of bile duct carcinoma in primary sclerosing cholangitis | 354 |
38 | Primary sclerosing cholangitis : indications for and recurrence after transplantation | 364 |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionCholestatic Liver Diseases: Therapeutic Options and Perspectives
X
This Item is in Your InventoryCholestatic Liver Diseases: Therapeutic Options and Perspectives
X
You must be logged in to review the productsX
X
X
Add Cholestatic Liver Diseases: Therapeutic Options and Perspectives, During the last decade, knowledge about cholestatic liver disease and concomitant diseases, such as ulcerative colitis, cholangio- and hepaellular carcinoma, pancreas and colon cancer, has increased considerably. Studies on ursodeoxycholic acid treatment , Cholestatic Liver Diseases: Therapeutic Options and Perspectives to the inventory that you are selling on WonderClubX
X
Add Cholestatic Liver Diseases: Therapeutic Options and Perspectives, During the last decade, knowledge about cholestatic liver disease and concomitant diseases, such as ulcerative colitis, cholangio- and hepaellular carcinoma, pancreas and colon cancer, has increased considerably. Studies on ursodeoxycholic acid treatment , Cholestatic Liver Diseases: Therapeutic Options and Perspectives to your collection on WonderClub |